These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9164930)

  • 21. Characterization of the new immunosuppressive drug undecylprodigiosin in human lymphocytes: retinoblastoma protein, cyclin-dependent kinase-2, and cyclin-dependent kinase-4 as molecular targets.
    Songia S; Mortellaro A; Taverna S; Fornasiero C; Scheiber EA; Erba E; Colotta F; Mantovani A; Isetta AM; Golay J
    J Immunol; 1997 Apr; 158(8):3987-95. PubMed ID: 9103470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine kinase inhibitor herbimycin A reduces the stability of cyclin-dependent kinase Cdk6 protein in T-cells.
    Akagi T; Ono H; Shimotohno K
    Oncogene; 1996 Jul; 13(2):399-405. PubMed ID: 8710379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of p21-CDC42/Rac-activated kinases by CD28 signaling: p21-activated kinase (PAK) and MEK kinase 1 (MEKK1) may mediate the interplay between CD3 and CD28 signals.
    Kaga S; Ragg S; Rogers KA; Ochi A
    J Immunol; 1998 May; 160(9):4182-9. PubMed ID: 9574518
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The regulation of p27Kip1 expression following the polyclonal activation of murine G0 T cells.
    Kwon TK; Buchholz MA; Ponsalle P; Chrest FJ; Nordin AA
    J Immunol; 1997 Jun; 158(12):5642-8. PubMed ID: 9190912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
    Li G; Domenico J; Lucas JJ; Gelfand EW
    J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the stress kinase pathway in signaling via the T cell costimulatory receptor 4-1BB.
    Cannons JL; Hoeflich KP; Woodgett JR; Watts TH
    J Immunol; 1999 Sep; 163(6):2990-8. PubMed ID: 10477561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ras initiates phosphatidyl-inositol-3-kinase (PI3K)/PKB mediated signalling pathways in untransformed human peripheral blood T lymphocytes.
    Samstag Y; Nebl G
    Adv Enzyme Regul; 2005; 45():52-62. PubMed ID: 16083947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/leukemia.
    Chilosi M; Doglioni C; Yan Z; Lestani M; Menestrina F; Sorio C; Benedetti A; Vinante F; Pizzolo G; Inghirami G
    Am J Pathol; 1998 Jan; 152(1):209-17. PubMed ID: 9422538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative and qualitative signals determine T-cell cycle entry and progression.
    Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
    Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins.
    Baghdassarian N; Catallo R; Mahly MA; Ffrench P; Chizat F; Bryon PA; Ffrench M
    Exp Cell Res; 1998 May; 240(2):263-73. PubMed ID: 9596999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.
    Nel AE; Hanekom C; Rheeder A; Williams K; Pollack S; Katz R; Landreth GE
    J Immunol; 1990 Apr; 144(7):2683-9. PubMed ID: 2156931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanism of cell cycle progression induced by the oncogene product Tax of human T-cell leukemia virus type I.
    Iwanaga R; Ohtani K; Hayashi T; Nakamura M
    Oncogene; 2001 Apr; 20(17):2055-67. PubMed ID: 11360190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines.
    Timmermann S; Hinds PW; Münger K
    Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increases in tyrosine phosphorylation are detectable before phospholipase C activation after T cell receptor stimulation.
    June CH; Fletcher MC; Ledbetter JA; Samelson LE
    J Immunol; 1990 Mar; 144(5):1591-9. PubMed ID: 1689750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
    Laxminarayana D; Kammer GM
    J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression and characterization of cyclin-dependent kinase 6 during the activation of murine G0 T-cells.
    Kwon TK; Park JW; Buchholz MA; Nordin AA
    Mol Cells; 2001 Dec; 12(3):313-20. PubMed ID: 11804329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells.
    Harris R; Yang M; Schmidt C; Royet C; Singh S; Natarajan A; Morris M; Frezza C; Laman H
    J Cell Biol; 2022 Jul; 221(7):. PubMed ID: 35670764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.